Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Re: US JSGPM program

5 Oct 2007 07:00

Avon Rubber PLC05 October 2007 Strictly embargoed until Friday, 5 October 2007 Avon Rubber p.l.c. ("Avon" or "the Group") Full rate production decision on M50 Mask for US JSGPM program The Joint Program Executive Officer for Chemical and Biological Defence, hasapproved the Joint Service General Purpose Mask ("JSGPM") Program for entry intothe Full Rate Production Phase of Systems Acquisition. The collaboration betweenAvon and the Joint Project Manager for Individual Protection has resulted inthis significant milestone which will allow Avon's Cadillac, Michigan plant toramp up to full rate production to support fielding of this product to the U.S.Armed Forces. This milestone allows the U.S. Government to exercise the fullrate production portion of its contract with Avon and commence full rateproduction and fielding. The first multi year order is planned at a rate of100,000 masks per annum for an initial contract period of five years withadditional orders for both masks and spares to follow. It is anticipated thatorders in the first year will exceed $40 million. The development of the M50 Mask by Avon has resulted in the world's mostadvanced respiratory protection mask, offering huge improvements in comfort,usability and operational effectiveness, as well as protection. It will replacethe M40 mask which has been in service with the US military for more than 15years. The JSGPM program is likely to become the largest respiratory protectioncontract and will equip all five US armed forces. Avon has managed the complexand technologically demanding development of the M50 to meet the JSGPMrequirement since being awarded the original contract in 2000. The M50 and its extensive range of associated products including the uniqueconformal filters and advanced visor, will be manufactured at Avon's state ofthe art production facility in Cadillac, Michigan. Commenting on the full rate production of the M50, Terry Stead, Chief Executiveof Avon Rubber p.l.c., said: "This is a wonderful day for Avon and puts us ontrack to become the largest supplier of military CBRN respirators. It is theresult of over seven years of dedicated effort working with the US Department ofDefense and we are very proud of this achievement." - Ends - For further enquiries, please contact: Avon Rubber p.l.c. 01225 896831Terry Stead, Chief Executive 01225 896871Fiona Stewart (Local/Trade Press) Weber Shandwick FinancialRichard Hews / Rachel Martin / Hannah Marwood 020 7067 0700 NOTES TO EDITORS: Avon Rubber p.l.c. is an international polymer engineeringgroup adding value through material, manufacturing and industry sectorexpertise. The Group is currently capitalised at approximately £45 million. Avonsupplies a range of advanced CBRN respiratory protection solutions through AvonProtection Systems Inc. to the world's military and police forces, as well asfirst responders and emergency services. Avon Rubber p.l.c. owns Avon-ISI, whichdesigns, develops and manufactures a range of self-contained breathing apparatusfor fire, rescue and law enforcement, as well as military applications. AvonRubber p.l.c. also owns Avon Engineered Fabrications manufacturing productsincluding hovercraft skirting and flexible storage tanks, an aerosol gasketbusiness and a world leading dairy business manufacturing dairy liners andtubing. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR
8th Jul 202412:00 pmRNSDirectors'/PDMR Shareholdings
6th Jun 20243:00 pmRNSDirectors'/PDMR Shareholdings
30th May 20245:00 pmRNSHolding(s) in Company
28th May 20245:00 pmRNSHolding(s) in Company
24th May 20244:00 pmRNSHolding(s) in Company
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.